The Investor's Guide to Asia

Fidelity International

We bring you ideas from Fidelity International's investment experts across the Asia Pacific region, helping you chart your path through these vibrant markets. With regular macro and market insights on China. Also published on this feed is Fidelity Answers, the investment podcast where we put the questions investors are asking to our portfolio managers and analysts. Looking for invaluable sector views, market commentary, and the best investment thinking? Then this is the place for you.

The Investor's Guide to Asia

The Investor’s Guide to Asia: Japan is back. But is this time different?

Episode discussion: Speakers argue Japan's reflation is structurally supported by wage growth and governance reforms, highlighting banks and mid-caps as key investment themes.

Speakers’ claims: Min Zeng and George Efstathopoulos discuss Japan's return to inflation and growth, attributing it to domestic reflation driven by nominal wage increases and shifting consumer expectations rather than temporary energy spikes. They highlight structural improvements in corporate governance, noting ROE has risen from 9% to 12%, and identify Japanese banks and mid-cap stocks as primary investment opportunities benefiting from deregulation and domestic revenue insulation. The speakers also address risks, including a potential global recession, while suggesting long-dated Japanese government bonds as a defensive hedge due to the yen's safe-haven status.

Japan EquitiesCorporate GovernanceWage Growth
38 min0 assets14 claims to verify
The Investor's Guide to Asia

Fidelity Answers BONUS: How investors can make the most of change

Episode discussion: Mark Schmehl discusses AI demand rationalization, healthcare opportunities, and active portfolio management with 200% turnover.

Guest: Mark Schmehl

Speakers’ claims: Mark Schmehl argues that AI data center construction is becoming a 'Darwinian' environment favoring hyperscalers due to permitting and financing hurdles, while AI demand is shifting from infinite assumptions to price-elastic rationalization. He identifies healthcare as a lucrative market where superintelligence could accelerate drug discovery, benefiting large pharmaceutical companies. Schmehl advocates for a global allocation strategy that blends growth and value, specifically seeking deep value in improving fundamentally bad companies. He describes his portfolio management philosophy as 'watering flowers and pulling weeds,' with an annual turnover of 200% to maintain quality. Additionally, he discusses using assets like gold for hedging against tech downturns, provided they remain uncorrelated with tech stocks.

AI Data CentersHealthcarePortfolio Management
23 min4 assets10 claims to verify